Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; there are no visible edits to the study details content.
    Difference
    0.1%
    Check dated 2026-03-21T16:52:39.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T13:19:07.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the conditions list. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T17:32:06.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added primary peritoneal carcinoma to the conditions and included the Genetic and Rare Diseases Information Center under resources. Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-06T11:35:40.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is displayed in place of v3.4.0, a minor version label update that does not affect study content or available actions for users.
    Difference
    0.1%
    Check dated 2026-02-05T12:54:01.000Z thumbnail image
  9. Check
    70 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated the QC status line to 'Last Update Submitted that Met QC Criteria.' Minor capitalization changes for 'No FEAR Act Data' and a site revision label 'Revision: v3.4.0' were also applied.
    Difference
    0.2%
    Check dated 2026-01-29T06:22:20.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.